ID   BLCA-38
AC   CVCL_6G47
SY   BLCA38; MIL-38
DR   Wikidata; Q54797332
RX   Patent=US5622836;
RX   PubMed=2685375;
RX   PubMed=27313791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11785.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35052; Human GPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
RX   Patent=US5622836;
RA   Walker K.Z., Russell P.J.;
RT   "Monoclonal antibodies which recognize malignant cells from bladder
RT   carcinomas.";
RL   Patent number US5622836, 22-Apr-1997.
//
RX   PubMed=2685375; DOI=10.1016/S0022-5347(17)39172-3;
RA   Walker K.Z., Russell P.J., Kingsley E.A., Philips J., Raghavan D.;
RT   "Detection of malignant cells in voided urine from patients with
RT   bladder cancer, a novel monoclonal assay.";
RL   J. Urol. 142:1578-1583(1989).
//
RX   PubMed=27313791; DOI=10.7150/jca.14645;
RA   Truong Q., Justiniano Fuenmayor I.O., Nocon A.L., Soon J.T.,
RA   Wissmueller S., Campbell D.H., Walsh B.J.;
RT   "Glypican-1 as a biomarker for prostate cancer: isolation and
RT   characterization.";
RL   J. Cancer 7:1002-1009(2016).
//